文献速递神经核医学

18F-FDG PET/CT 显像与临床参数选择亨廷顿病神经退变模型参考区

Selection of Reference Regions to Model Neurodegeneration in Huntington Disease by 18F-FDG PET/CT Using Imaging and Clinical Parameters.
PubMed 文献 · Clin Nucl Med · 2019-01-01

研究纳入38例显性HD、20例前显性HD和18例健康对照,行脑18F-FDG PET/CT,比较 atlas 定义参考区与体素统计参考簇,用基底节SUVr与疾病负担评分(DBS)的相关性评估参考区稳定性。结果显示脑桥可能是计算SUVr以建模HD神经代谢退变的稳定可靠参考区。

要点

  • 脑桥可能是计算SUVr以建模HD神经代谢退变的稳定可靠参考区。
  • 前显性HD中,脑桥-小脑蚓部ROI、丘脑及脑桥/丘脑参考簇下基底节SUVr与DBS相关显著。
  • 显性HD中,颞叶及额叶白质参考簇下基底节SUVr与DBS相关显著。

核心结论

  • 脑桥可能是计算SUVr以建模HD神经代谢退变的稳定可靠参考区。

研究设计与样本

  • 研究纳入38例显性HD患者(平均年龄54±14.3岁,CAG重复44.2±3.1)、20例前显性HD患者(平均年龄42.7±11.7岁,CAG重复40±3.8)和18例健康对照(平均年龄45±13.2岁),行脑18F-FDG PET/CT。
  • 定量分析选取MNI空间图集定义的参考区(脑桥、全小脑、大脑白质、丘脑及脑桥-小脑蚓部ROI)和体素统计组间比较获得的参考簇(P<0.05 FWE;体素阈值k=200)。
  • 每个候选参考区和参考簇均用影像参数(基底节SUVr)与临床参数(DBS)进行定量评估。

主要发现

  • HD与NC比较获得小脑、颞叶和额叶参考簇;显性HD与前显性HD比较获得小脑、脑桥、丘脑、顶叶和楔叶参考簇。
  • 所有HD患者中,参考区集合显示基底节SUVr与DBS显著相关。
  • 前显性HD患者中,使用脑桥-小脑蚓部ROI、丘脑定义参考区及脑桥和丘脑参考簇时,基底节SUVr与DBS相关显著。
  • 显性HD患者中,使用颞叶和额叶白质参考簇时相关显著。
  • NC中参考区与参考簇集合的SUVr方差极小。

关键数值与推荐

  • 体素统计组间比较采用P<0.05 FWE,体素范围阈值k=200。
  • 参考区包括脑桥、全小脑、大脑白质、丘脑及脑桥-小脑蚓部ROI。

临床怎么用

  • 在定量18F-FDG PET显像中,脑桥可能作为计算SUVr的稳定可靠参考区用于建模HD神经代谢退变。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Normalization to an appropriate reference region in F-FDG PET imaging may enhance diagnostic performance in Huntington disease (HD). We aimed to identify stable brain areas that could be used to model neurometabolic degeneration in HD correlating imaging (SUVrvalues at the basal ganglia [BBGG]) and clinical parameters (disease burden score [DBS]). MATERIALS AND METHODS: We performed brain F-FDG PET/CT in 38 manifest HD patients (meanage ± SD, 54 ± 14.3 years; CAGrepeats ± SD, 44.2 ± 3.1), 20 premanifest HD patients (meanage ± SD, 42.7 ± 11.7 years; CAGrepeats ± SD, 40 ± 3.8), and 18 healthy controls (NC; meanage ± SD, 45 ± 13.2 years). For quantitative analysis, we selected (a) defined reference regions from the Montreal Neurological Institute space atlas (pons, whole cerebellum, cerebral white matter, thalamus, and a pons-cerebellar vermis region of interest), and (b) reference clusters obtained by voxelwise statistical comparison across groups (P < 0.05 FWE; extent voxel threshold k = 200). Each candidate reference region and reference cluster was quantitatively assessed using imaging and clinical parameters. RESULTS: Comparing HD and NC groups, we obtained a reference cluster in the cerebellum, and in temporal and frontal lobes. Comparing manifest HD and premanifest HD patients, we observed reference clusters in the cerebellum, pons, thalamus, parietal lobe, and cuneus. The set of reference regions showed a significant correlation between SUVrvalues at the BBGG and DBS in all HD patients. In premanifest HD patients, the correlation between SUVrvalues at the BBGG and DBS was significant using the pons-cerebellar vermis region of interest, the thalamus as defined reference regions, and the pons and thalamus as reference clusters. In manifest HD patients, the correlation was significant using the temporal and white matter frontal lobe clusters. Variance between SUVrvalues in the set of reference regions and reference clusters was minimal within NC. CONCLUSIONS: The pons may be a stable and reliable region to calculate SUVrvalues to model the neurometabolic degeneration in quantitative F-FDG PET imaging in HD.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. López Mora DA, Sampedro F, Camacho V, et al. Selection of Reference Regions to Model Neurodegeneration in Huntington Disease by 18F-FDG PET/CT Using Imaging and Clinical Parameters. Clin Nucl Med. 2019. PMID: 30325816. doi:10.1097/RLU.0000000000002329

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。